Por Galtec | octubre 30, 2023

Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology

Nadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, Pablo F Hockl, Juan M Pérez Sáez, P Alfredo García, Yamil D Mahmoud, Julián Gambarte Tudela, Marco A Scheidegger, Andrea Marshall, Pippa G Corrie, Mark R Middleton, Karina V Mariño, M Romina Girotti, Diego O Croci, Gabriel A Rabinovich

Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2214350120. doi: 10.1073/pnas.2214350120. Epub 2023 Jan 12